Workup and Management of Premenopausal Osteoporosis.

Humans Female Osteoporosis / therapy Premenopause Bone Density Risk Factors
Bone mineral density Estrogen Fracture Premenopausal and perimenopausal osteoporosis Z-scores

Journal

Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 24 10 2024
Statut: ppublish

Résumé

The diagnosis and management of premenopausal low bone mass or osteoporosis is challenging as its relationship to low bone mass and risk of fracture is less defined. Premenopausal or perimenopausal women with low bone density or a history of fragility fractures should undergo a thorough evaluation of causes that predispose them to bone loss. Identification of these underlying risk factors such as estrogen deficiency or malabsorptive disorders offers a treatment strategy to reverse bone loss. This is a review of the diagnostic approach and subsequent management strategies of premenopausal low bone mass or osteoporosis.

Identifiants

DOI: 10.1016/j.ecl.2024.08.005 PMID: 39448139
pubmed: 39448139
pii: S0889-8529(24)00062-8
doi: 10.1016/j.ecl.2024.08.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

597-606

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Marriam Ali (M)

Department of Endocrinology, Osteoporosis and Metabolic Bone Disease Center, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA. Electronic address: marriam.ali@lumc.edu.

Pauline M Camacho (PM)

Department of Endocrinology, Osteoporosis and Metabolic Bone Disease Center, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Workup and Management of Premenopausal Osteoporosis.
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Maladies osseuses métaboliques › Ostéoporose › Workup and Management of Premenopausal Osteoporosis.
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Développement sexuel › Climatère › Ménopause › Préménopause › Workup and Management of Premenopausal Osteoporosis.
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Densité osseuse › Workup and Management of Premenopausal Osteoporosis.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Workup and Management of Premenopausal Osteoporosis.